Recurrent High-grade Glioma Clinical Trials

19 clinical trials for Recurrent High-grade Glioma across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma — RECRUITING · PHASE1
• Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252 — RECRUITING · PHASE1
• Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma. — RECRUITING · PHASE1
• Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma — RECRUITING · PHASE1
• Recurrent High Grade Glioma Treated by LITT — RECRUITING · NA
• CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults — RECRUITING · PHASE1
• RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma — WITHDRAWN · PHASE1
• Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas — TERMINATED · PHASE1
• PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas — ACTIVE_NOT_RECRUITING · PHASE1
• Study to Assess Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG) — WITHDRAWN · PHASE1
• AsiDNA Children, Adolescents and Young Adults — TERMINATED · PHASE1
• Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma — COMPLETED · NA
• A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma — OTHER · PHASE2
• Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma — OTHER · PHASE2
• A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas — COMPLETED · PHASE1
• Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas — OTHER · NA
• A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation — OTHER · NA

Refine this search